Healthcare & Life Sciences
Metaimmune Therapeutics
Germany
About
Metaimmune Therapeutics develops therapies as a lower-side-effect alternative to corticosteroids, focusing on novel anti-inflammatory and immunomodulatory drugs.
Explore Metaimmune Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.